Function of the PDLIM2 protein in oncogenic Wnt signalling pathways

dc.check.embargoformatE-thesis on CORA onlyen
dc.check.entireThesisEntire Thesis Restricted
dc.check.reasonThis thesis is due for publication or the author is actively seeking to publish this materialen
dc.contributor.advisorO'Connor, Rosemaryen
dc.contributor.authorBustamante- Garrido, Milán F.
dc.contributor.funderHealth Research Boarden
dc.description.abstractAberrant regulation of the Wnt signalling pathway is a recurrent theme in cancer biology. Hyper activation due to oncogenic mutations and paracrine activity has been found in both colon cancer and breast cancer, and continues to evolve as a central mechanism in oncogenesis. PDLIM2, a cytoskeletal PDZ protein, is an IGF-1 regulated gene that is highly expressed in cancer cell lines derived from metastatic tumours. Suppression of PDLIM2 inhibits polarized cell migration, reverses the Epithelial to Mesenchymal transition (EMT) phenotype, suppresses the transcription of β-catenin target genes, and regulates gene expression of key transcription factors in EMT. This thesis investigates the mechanism by which PDLIM2 contributes to the maintenance of Wnt signalling in cancer cells. Here we show that PDLIM2 is a critical regulator of the Wnt pathway by regulating β-catenin at the adherens juctions, as also its transcriptional activity by the interaction of PDLIM2 with TCF4 at the nucleus. Evaluation of PDLIM2 in macrophages and co-culture studies with cancer cells and fibroblasts showed the influence exerted on PDLIM2 by paracrine cues. Thus, PDLIM2 integrates cytoskeleton signalling with gene expression by modulating the Wnt signalling pathway and reconciling microenvironmental cues with signals in epithelial cells. Negative correlation of mRNA and protein levels in the triple negative breast cancer cell BT549 suggests that PDLIM2 is part of a more complex mechanism that involves transcription and posttranslational modifications. GST pulldown studies and subsequent mass spectrometry analysis showed that PDLIM2 interacts with 300 proteins, with a high biological function in protein biosynthesis and Ubiquitin/proteasome pathways, including 13 E3 ligases. Overall, these data suggest that PDLIM2 has two distinct functions depending of its location. Located at the cytoplasm mediates cytoskeletal re-arrangements, whereas at the nucleus PDLIM2 acts as a signal transduction adaptor protein mediating transcription and ubiquitination of key transcription factors in cancer development.en
dc.description.statusNot peer revieweden
dc.description.versionAccepted Version
dc.identifier.citationBustamante- Garrido, M. F. 2016. Function of the PDLIM2 protein in oncogenic Wnt signalling pathways. PhD Thesis, University College Cork.en
dc.publisherUniversity College Corken
dc.rights© 2016, Milán F. Bustamante- Garrido.en
dc.subjectEpithelial to mesenchymal transitionen
dc.subjectWnt signallingen
dc.subjectParacrine activityen
dc.subjectCancer biologyen
dc.titleFunction of the PDLIM2 protein in oncogenic Wnt signalling pathwaysen
dc.typeDoctoral thesisen
dc.type.qualificationlevelDoctoral Degree (Structured)en
dc.type.qualificationnamePhD Scholars Programme in Cancer Biologyen
License bundle
Now showing 1 - 2 of 2
Thumbnail Image
5.62 KB
Item-specific license agreed upon to submission
Thumbnail Image
Decision To Withold EThesis Autumn 2016 Milan Bustamante- Garrido.pdf
25.87 KB
Adobe Portable Document Format
Opt-Out Form